Tachycardia, Ventricular Clinical Trial
Official title:
CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients With Refractory Ventricular Tachycardia
The objective of this clinical investigation is to evaluate: 1. the safety and efficacy of the CyberHeart System, CardioPlan™ Software and Laptop, in treating patients with refractory ventricular tachycardia (VT) using the CyberKnife® Radiosurgical System. 2. The CyberHeart System performance with respect to the ability to contour myocardial targets that are transferred to the Multi-plan® Treatment Planning Software of the CyberKnife® system for the production and delivery of a safe radiosurgical treatment plan. Cardiac radiosurgery is a minimally-non invasive, painless, procedure. Tissue ablation can be accomplished precisely.
This study is a prospective, multi-center (2), single arm, open label US-based feasibility study. The clinical hypothesis for the study is that the CyberHeart treatment approach will be safe and with further study will not be shown to be inferior to current treatment options, may lead to a survival benefit and improved quality of life. The ablation to be performed with the CyberHeart System will be targeting the anatomical site of the clinically presenting VT. The application site will be determined by morphological criteria on the 12 lead ECG along with anatomical data from MRI or CT scan imaging. Ablation will be performed at the designated location with the intention to produce substrate modification. The Study will enroll a maximum of 10 patients. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01546207 -
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
|
N/A | |
| Completed |
NCT04075253 -
Acute Effect of One Single Bout of High Intensity Exercise on the Tendency for Ventricular Arrhythmia
|
N/A | |
| Completed |
NCT04070300 -
Physical Activity and Ventricular Arrhythmias
|
N/A | |
| Completed |
NCT00000531 -
Antiarrhythmics Versus Implantable Defibrillators (AVID)
|
Phase 3 | |
| Completed |
NCT00000480 -
Multicenter Unsustained Tachycardia Trial (MUSTT)
|
Phase 3 | |
| Completed |
NCT05086510 -
Ablation Targets of Scar-related Ventricular Tachycardia Identified by Dynamic Functional Substrate Mapping
|
N/A | |
| Completed |
NCT01940081 -
The Leiden Nonischemic Cardiomyopathy Study
|
||
| Recruiting |
NCT01222156 -
Accuracy and Safety Study of the Magnetecs CGCI System for Intracardiac Mapping
|
Phase 1/Phase 2 | |
| Terminated |
NCT00749671 -
Bispectral Index Monitoring During Testing in the Electrophysiology Lab
|
N/A | |
| Recruiting |
NCT00385749 -
Right Ventricular Defibrillation Lead Select Site Study
|
N/A | |
| Completed |
NCT00382928 -
Automatic External Defibrillation Monitoring in Cardiac Arrest
|
Phase 1 | |
| Completed |
NCT00279279 -
PREPARE - Primary Prevention Parameters Evaluation
|
N/A | |
| Terminated |
NCT00776087 -
European Health Economic Trial on Home Monitoring in ICD and CRT-D Patients (EuroEco)
|
N/A | |
| Withdrawn |
NCT00510731 -
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
|
N/A | |
| Completed |
NCT01572246 -
Effects of Monopolar Electrocautery Use During Surgery on Implanted Cardiac Defibrillators
|
N/A | |
| Completed |
NCT00170287 -
SMS: Substrate Modification Study in Patients Getting an Implantable Cardioverter Defibrillator (ICD)
|
Phase 4 | |
| Completed |
NCT00147277 -
ADVANCE-D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy
|
Phase 4 | |
| Completed |
NCT00004559 -
Fatty Acid Antiarrhythmia Trial (FAAT)
|
Phase 3 | |
| Completed |
NCT00702117 -
Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias
|
Phase 4 | |
| Completed |
NCT00232297 -
Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS
|
Phase 2 |